Literature DB >> 8322658

Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents.

M Haude1, R Erbel, H Issa, U Straub, H J Rupprecht, N Treese, J Meyer.   

Abstract

Despite excellent results as a bail-out procedure for the management of abrupt closure after balloon angioplasty and the potential beneficial effects on restenosis after angioplasty, intracoronary stenting is limited, especially by subacute stent thrombosis. In 100 consecutive patients with intracoronary implantation of 118 Palmaz-Schatz stents, 10 patients (10%) developed subacute stent thrombosis during their hospital course 3 to 9 days after implantation. Therapy included intravenous thrombolysis, mechanical recanalization by balloon angioplasty, and emergency bypass surgery. Although successful recanalization was maintained in eight of nine nonsurgically treated patients within 2 hours after the onset of symptoms, seven patients developed myocardial infarction, with two patients having Q wave myocardial infarction and five patients having non-Q wave myocardial infarction. By univariate analysis, several variables could be identified as risk factors for the development of subacute stent thrombosis: bail-out implantations (odds ratio: 6.42; 95% confidence interval: 1.53 to 26.38; p = 0.007), unstable angina (12.32; 1.50 to 101.37; p = 0.006), long (5.44; 1.31 to 22.65; p = 0.015) and complex (type C) lesions (8.17; 1.93 to 34.50; p = 0.002) with large plaque areas (9.85; 1.96 to 44.51; p = 0.002), symptomatic postangioplasty dissections (4.36; 1.10 to 16.90; p = 0.029), incomplete wrapping of the dissection after stenting (6.50; 1.10 to 42.30; p = 0.039), and vessel irregularities distal to the stented segment (21.70; 4.12 to 113.18; p < 0.001). These variables, except the variable large plaque area, were confirmed as independent predictors of subacute stent thrombosis by a stepwise multivariate logistic regression analysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8322658     DOI: 10.1016/s0002-8703(07)80005-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

Review 1.  Stent thrombosis: historical perspectives and current trends.

Authors:  D E Cutlip
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

2.  Changes in membrane glycoproteins of circulating platelets after coronary stent implantation.

Authors:  M Gawaz; F J Neumann; I Ott; A May; S Rüdiger; A Schömig
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

3.  [Clinical pharmacology of current antiplatelet drugs].

Authors:  D Trenk; T Nührenberg; C Stratz; C M Valina; W Hochholzer
Journal:  Herz       Date:  2014-11       Impact factor: 1.443

4.  Coronary artery stenting in unstable angina pectoris: a comparison with stable angina pectoris.

Authors:  P B Clarkson; M Halim; K K Ray; S Doshi; M Been; H Singh; M F Shiu
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

5.  Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results.

Authors:  Dong Joon Kim; Byung Hee Lee; Dong Ik Kim; Won Heum Shim; Pyoung Jeon; Tae Hong Lee
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

6.  Coronary Palmaz-Schatz stent implantation in acute myocardial infarction.

Authors:  F J Neumann; H Walter; G Richardt; C Schmitt; A Schömig
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

7.  Intravascular ultrasound-guided emergency coronary Palmaz-Schatz stent placement without post-procedural systemic anticoagulation.

Authors:  R Blasini; F J Neumann; G Richardt; C Schmitt; R Paloncy; A Schömig
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

8.  Early and intermediate term clinical outcome after multiple coronary stenting.

Authors:  A Chauhan; E Vu; D R Ricci; C E Buller; M D Moscovich; S Monkman; I M Penn
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

9.  Antiplatelet treatment with cilostazol after stent implantation.

Authors:  Y Yoshitomi; S Kojima; T Sugi; M Yano; Y Matsumoto; M Kuramochi
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

10.  Clinical experience with the Wiktor stent in native coronary arteries and coronary bypass grafts.

Authors:  S Vaishnav; S Aziz; C Layton
Journal:  Br Heart J       Date:  1994-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.